Polymeric pH nanosensor with extended measurement range bearing octaarginine as cell penetrating peptide

A synthetic peptide octaarginine which mimics human immunodeficiency virus‐1, Tat protein is used as cell penetrating moiety for new pH nanosensors which demonstrate enhanced cellular uptake and expanded measurement range from pH 3.9 to pH 7.3 by simultaneously incorporating two complemental pH‐sensitive fluorophores in a same nanoparticle. The authors believe that this triple fluorescent pH sensor provides a new tool to pH measurements that can have application in cellular uptake mechanism study and new nanomedicine design

Investigating the Nexus of NLRP3 Inflammasomes and COVID-19 Pathogenesis: Unraveling Molecular Triggers and Therapeutic Strategies

The coronavirus disease 2019 (COVID-19) global pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), has been marked by severe cases demonstrating a “cytokine storm”, an upsurge of pro-inflammatory cytokines in the bloodstream. NLRP3 inflammasomes, integral to the innate immune system, are speculated to be activated by SARS-CoV-2 within host cells. This review investigates the potential correlation between NLRP3 inflammasomes and COVID-19, exploring the cellular and molecular mechanisms through which SARS-CoV-2 triggers their activation. Furthermore, promising strategies targeting NLRP3 inflammasomes are proposed to mitigate the excessive inflammatory response provoked by SARS-CoV-2 infection. By synthesizing existing studies, this paper offers insights into NLRP3 as a therapeutic target, elucidating the interplay between COVID-19 and its pathophysiology. It serves as a valuable reference for future clinical approaches in addressing COVID-19 by targeting NLRP3, thus providing potential avenues for therapeutic intervention

Impact of individual ε mutations on viral DNA accumulation.

<p>HepG2 cells were transfected with the wild-type (wt) HBV expression vector pCH-9/3091, or derivatives containing the mutant 5′ ε sequences shown in Fig. 2B. The + or − signs indicate whether canonical base-pairs could form between residues at the A1-U29 and A2-U28 positions; potential G-U pairs are separately indicated. Viral DNAs from cytoplasmic nucleocapsids were monitored by Southern blotting (top panel) using a ³²P-labeled HBV DNA probe; M, 3.2 kb restriction fragment corresponding to a unit length double-stranded linear (dsL) HBV genome. As controls, core protein and β-actin mRNA levels in the source lysates were monitored by Western blotting (middle panel) and RT-PCR (lower panel). Numbers below each lane show the accumulation of viral DNA replicative intermediates, measured by phosphorimaging, relative to those produced by the wild-type HBV construct which was set to 100. Mean values ± standard deviation were derived from two independent experiments.</p

Sequences of investigated ε mutants and summary of phenotypes.

a)<p>Values are categorized relative to wild-type HBV (100%) as follows: +++, 66–100%; ++, 33–65%; +, 25–32%; +/−, 10–24%; −, not detectable; nd, not determined. ^b) Derived by visual inspection of the autoradiograms shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0072798#pone-0072798-g003" target="_blank">Fig. 3</a>.</p